Compare Stocks

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CMG Chipotle Mexican Grill	$2,850.76 -2.0%	$2,778.61	$1,768.64 ▼ $3,023.98	$78.17B	1.28	230,918 shs	217,122 shs
PINS Pinterest	$32.42 -1.5%	$34.87	$20.60 ▼ $41.60	$22.01B	0.99	9.47 million shs	4.73 million shs
TEVA Teva Pharmaceutical Industries	$12.78	$13.48	$7.09 ▼ $14.47	$14.33B	1.05	10.63 million shs	7.15 million shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CMG Chipotle Mexican Grill	+0.25%	-2.77%	+3.95%	+24.56%	+61.11%
PINS Pinterest	+0.41%	-3.25%	-2.88%	-11.28%	+16.64%
TEVA Teva Pharmaceutical Industries	-3.11%	-7.79%	-4.20%	+14.31%	+50.53%

Don’t expose yourself to stocks during the week (Ad)

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CMG Chipotle Mexican Grill	4.0506 of 5 stars	2.3	3.0	2.0	3.7	2.5	2.5
PINS Pinterest	3.6361 of 5 stars	3.4	5.0	0.0	2.4	2.5	1.9
TEVA Teva Pharmaceutical Industries	1.5801 of 5 stars	2.4	3.0	0.0	2.7	1.7	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CMG Chipotle Mexican Grill	2.64	Moderate Buy	$2,759.14	-3.21% Downside
PINS Pinterest	2.74	Moderate Buy	$37.97	17.11% Upside
TEVA Teva Pharmaceutical Industries	2.70	Moderate Buy	$13.78	7.81% Upside

Current Analyst Ratings

Latest CMG, TEVA, and PINS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/18/2024	CMG Chipotle Mexican Grill	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$2,900.00 ➝ $3,200.00
4/16/2024	CMG Chipotle Mexican Grill	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$2,350.00 ➝ $2,700.00
4/12/2024	CMG Chipotle Mexican Grill	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$2,500.00 ➝ $2,986.00
4/12/2024	CMG Chipotle Mexican Grill	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$3,010.00
4/11/2024	CMG Chipotle Mexican Grill	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2,900.00 ➝ $3,400.00
4/11/2024	CMG Chipotle Mexican Grill	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2,700.00 ➝ $3,270.00
4/10/2024	CMG Chipotle Mexican Grill	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$2,900.00
4/9/2024	CMG Chipotle Mexican Grill	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$2,750.00 ➝ $3,250.00
4/8/2024	CMG Chipotle Mexican Grill	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$3,016.00 ➝ $3,358.00
4/4/2024	CMG Chipotle Mexican Grill	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$3,265.00 ➝ $3,366.00
3/26/2024	PINS Pinterest	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$48.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CMG Chipotle Mexican Grill	$9.87B	7.92	$55.91 per share	50.99	$111.58 per share	25.55
PINS Pinterest	$3.06B	7.21	$0.16 per share	199.93	$4.56 per share	7.11
TEVA Teva Pharmaceutical Industries	$15.85B	0.90	$3.41 per share	3.75	$7.25 per share	1.76

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CMG Chipotle Mexican Grill	$1.23B	$44.35	64.28	43.99	2.46	12.45%	44.41%	16.27%	4/24/2024 (Confirmed)
PINS Pinterest	-$35.61M	-$0.06	N/A	49.12	4.49	-1.17%	3.83%	3.26%	4/30/2024 (Confirmed)
TEVA Teva Pharmaceutical Industries	-$559M	-$0.47	N/A	5.09	1.58	-3.33%	34.90%	6.48%	5/8/2024 (Confirmed)

Latest CMG, TEVA, and PINS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2024	N/A	TEVA Teva Pharmaceutical Industries	$0.49	N/A	-$0.49	N/A	N/A	N/A
4/30/2024	N/A	PINS Pinterest	$0.1360	N/A	-$0.1360	N/A	N/A	N/A
4/24/2024	N/A	CMG Chipotle Mexican Grill	$11.34	N/A	-$11.34	N/A	N/A	N/A
2/8/2024	Q4 2023	PINS Pinterest	$0.25	$0.29	+$0.04	$0.29	$988.62 million	$981.26 million
2/6/2024	Q4 2023	CMG Chipotle Mexican Grill	$9.73	$10.36	+$0.63	$10.51	$2.49 billion	$2.52 billion
1/31/2024	Q4 2023	TEVA Teva Pharmaceutical Industries	$0.73	$0.98	+$0.25	$1.55	$3.97 billion	$4.46 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CMG Chipotle Mexican Grill	N/A	N/A	N/A	N/A	N/A
PINS Pinterest	N/A	N/A	N/A	N/A	N/A
TEVA Teva Pharmaceutical Industries	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CMG Chipotle Mexican Grill	N/A	1.57	1.53
PINS Pinterest	N/A	10.53	10.53
TEVA Teva Pharmaceutical Industries	2.23	1.02	0.69

Ownership

Institutional Ownership

Company	Institutional Ownership
CMG Chipotle Mexican Grill	91.31%
PINS Pinterest	88.81%
TEVA Teva Pharmaceutical Industries	54.05%

Insider Ownership

Company	Insider Ownership
CMG Chipotle Mexican Grill	0.96%
PINS Pinterest	6.85%
TEVA Teva Pharmaceutical Industries	0.62%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CMG Chipotle Mexican Grill	116,068	27.42 million	27.16 million	Optionable
PINS Pinterest	4,014	678.98 million	632.47 million	Optionable
TEVA Teva Pharmaceutical Industries	37,851	1.12 billion	1.11 billion	Optionable

CMG, TEVA, and PINS Headlines

Source	Headline
	Number of Cape pharmacies ditch Israeli medicines to become ‘Apartheid Free Zone’ msn.com - April 19 at 7:21 AM
	Alvotech, Teva signs deal to expand access for Humira biosimilar in U.S. msn.com - April 19 at 7:21 AM
	Teva Pharmaceutical Industries Limited (NYSE:TEVA) to Post Q2 2025 Earnings of $0.57 Per Share, Zacks Research Forecasts americanbankingnews.com - April 19 at 3:02 AM
	3 Generic Drug Stocks to Watch Amid Challenging Market Prospects zacks.com - April 18 at 12:16 PM
	Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch biospace.com - April 18 at 10:05 AM
	Zacks Research Analysts Boost Earnings Estimates for Teva Pharmaceutical Industries Limited (NYSE:TEVA) marketbeat.com - April 18 at 6:31 AM
	USFDA approves Selarsdi injection for subcutaneous use to treat severe plaque psoriasis, active psoriatic arthritis: Alvotech, Teva medicaldialogues.in - April 17 at 5:34 PM
	Migdal Insurance & Financial Holdings Ltd. Acquires 1,860,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) marketbeat.com - April 17 at 2:37 PM
	Alvotech and Teva win FDA approval of Stelara copy thepharmaletter.com - April 17 at 12:31 PM
	Alvotech and Teva gain FDA approval of SELARSDI for psoriasis pharmaceutical-technology.com - April 17 at 7:30 AM
	Teva CEO Francis becomes highest paid TASE co exec en.globes.co.il - April 17 at 7:30 AM
	Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets finance.yahoo.com - April 16 at 8:42 AM
	Harel Insurance Investments & Financial Services Ltd. Has $297.89 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA) marketbeat.com - April 14 at 1:28 PM
	Teva Pharmaceutical Industries (NYSE:TEVA) Trading Down 5.3% americanbankingnews.com - April 14 at 4:42 AM
	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Average Recommendation of "Moderate Buy" from Analysts americanbankingnews.com - April 13 at 4:52 AM
	Teva announces phase 3 study of Ajovy for prevention of migraine achieves primary and all secondary endpoints pharmabiz.com - April 13 at 1:45 AM
	Teva Pharmaceutical Industries (NYSE:TEVA) Shares Down 5.3% marketbeat.com - April 12 at 2:51 PM
	Meitav Investment House Ltd. Acquires 1,950,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) marketbeat.com - April 12 at 12:48 AM
	Pfizer unit to settle Effexor XR antitrust claims in $39M deal msn.com - April 11 at 1:28 PM
	Teva Confirms Efficacy, Safety Of AJOVY In Prevention Of Migraine - Quick Facts markets.businessinsider.com - April 11 at 1:28 PM
	Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China businesswire.com - April 11 at 8:30 AM
	Stock Traders Buy High Volume of Teva Pharmaceutical Industries Call Options (NYSE:TEVA) americanbankingnews.com - April 10 at 1:16 AM
	Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024 businesswire.com - April 9 at 4:30 PM
	Teva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA) marketbeat.com - April 9 at 2:46 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
5 Top-Rated Dividend Stocks With Double-Digit Upside
March 25, 2024 11:19 AM
View 5 Top-Rated Dividend Stocks With Double-Digit Upside
4 Overbought Household Names, Time for a Pullback?
March 25, 2024 9:35 AM
View 4 Overbought Household Names, Time for a Pullback?

All Headlines

Company Descriptions

Chipotle Mexican Grill

NYSE:CMG

Chipotle Mexican Grill, Inc., together with its subsidiaries, owns and operates Chipotle Mexican Grill restaurants. It sells food and beverages through offering burritos, burrito bowls, quesadillas, tacos, and salads. The company also provides delivery and related services its app and website. It has operations in the United States, Canada, France, Germany, and the United Kingdom. Chipotle Mexican Grill, Inc. was founded in 1993 and is headquartered in Newport Beach, California.

NYSE:PINS

Pinterest, Inc. operates as a visual search and discovery platform in the United States and internationally. Its platform allows people to find ideas, such as recipes, home and style inspiration, and others; and to search, save, and shop the ideas. The company was formerly known as Cold Brew Labs Inc. and changed its name to Pinterest, Inc. in April 2012. Pinterest, Inc. was incorporated in 2008 and is headquartered in San Francisco, California.

Teva Pharmaceutical Industries

NYSE:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial